Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sue Deayton"'
Autor:
Robert Carroll, MD, (A)ACHI, Julie Turgeon, PhD, Sue Deayton, BSc (Hons), Tim Emery, BSc, Fiona Bilogrevic, Certificate, Sadia Jahan, MD, Annie Karakeussian Rimbaud, BSc, Barbara Georges, MD, Alexandre Tavares-Brum, BSc, Marie-Josée Hébert, MD, Héloïse Cardinal, MD, PhD
Publikováno v:
Transplantation Direct, Vol 9, Iss 2, p e1437 (2023)
Background. Both angiotensin II receptor autoantibodies (ATRabs) and autoantibodies to LG3 have been linked to kidney graft rejection with alloimmune vascular injury (AVI). We aimed to examine whether positivity for both anti-LG3 and ATRabs is associ
Externí odkaz:
https://doaj.org/article/ffdf59fb0a6845a8877f4be26f1b92c8
Autor:
Rob Caroll, Ian Humphreys, Toby Coates, Soo Jin Lim, Tim Emery, Soo Kun Lim, Sue Deayton, Maisarah Jalalonmuhali
Publikováno v:
Human Immunology. 81:679-684
Background Angiotensin II type 1 receptor antibody (AT1R-Ab) is a non-HLA antibody that has been reported to cause antibody-mediated rejection and graft loss in kidney transplantation. The prevalence of positive AT1R-Ab varies between 8% and 18% in d
Autor:
Adrian Fleet, Sue Deayton, Maisarah Jalalonmuhali, Timothy Emery, Robert P. Carroll, Ian Humphreys, Eleni Tsiopelas, Meg Lake, Watsala Munasinghe, Patrick Coates
Publikováno v:
Human immunology. 80(8)
High levels of angiotensin receptor antibodies (ATRab) are associated with acute cellular and humoral rejection, vascular occlusion, de novo human leucocyte antigen donor specific antibody (HLA DSA) and poor graft survival in kidney transplant recipi
Autor:
Nitesh N. Rao, Anjelo Jobert, Duska Dragun, Patrick T. Coates, Sue Deayton, James Nolan, John Brealey, Greg Bennett, Robert P. Carroll
Publikováno v:
Nephrology. 20:10-12
Atypical non HLA antibodies are increasingly recognised as causes of immunological injury in allotransplantation. In this report we describe a non HLA sensitized male renal allograft recipient who developed acute vascular rejection on a “for cause
Autor:
Robert P. Carroll, Michael D. Riceman, Sue Deayton, Anna Zeng, Christopher M. Hope, Greg Bennett, P.T. Coates
Angiotensin II type 1 antibodies (AT1Rab) can mediate antibody mediated rejection (AMR). Pre transplant AT1Rab levels, and risk of rejection were assessed in Kidney Transplant Recipients (KTR) transplanted in our centre from 2013 to 2014 (n = 145). 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d2f438e4535d886bbcf67553413e15
https://hdl.handle.net/11541.2/127135
https://hdl.handle.net/11541.2/127135